Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity

被引：0
|
作者：
Noortje M van Maarseveen
Dan Andersson
Martin Lepšík
Axel Fun
Pauline J Schipper
Dorien de Jong
Charles AB Boucher
Monique Nijhuis
机构：
[1] University Medical Center Utrecht,Dept. of Medical Microbiology, Virology
[2] Institute of Organic Chemistry and Biochemistry,Gilead Sciences and IOCB Research Center Prague
[3] v.v.i.,Dept. of Virology
[4] Academy of Science of the Czech Republic,undefined
[5] Erasmus Medical Center,undefined
来源：
Retrovirology | / 9卷
关键词：
HIV-1; Protease; Resistance; Gag; Cleavage; Replicative capacity; NC/p1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity
    van Maarseveen, Noortje M.
    Andersson, Dan
    Lepsik, Martin
    Fun, Axel
    Schipper, Pauline J.
    de Jong, Dorien
    Boucher, Charles A. B.
    Nijhuis, Monique
    [J]. RETROVIROLOGY, 2012, 9
  • [2] Gag NC/p1 protease resistance mutations can cause selection of additional NC/p1 changes to optimize cleavage efficiency and replicative capacity
    Maarseveen, N. M. Van
    Schipper, P. J.
    De Jong, D.
    Boucher, C. A. B.
    Nijuis, M.
    [J]. ANTIVIRAL THERAPY, 2008, 13 (04) : A52 - A52
  • [3] THE GAG PRECURSOR CONTAINS A SPECIFIC HIV-1 PROTEASE CLEAVAGE SITE BETWEEN THE NC (P7) AND P1 PROTEINS
    WONDRAK, EM
    LOUIS, JM
    DEROCQUIGNY, H
    CHERMANN, JC
    ROQUES, BP
    [J]. FEBS LETTERS, 1993, 333 (1-2) : 21 - 24
  • [4] Novel HIV gag based protease drug resistance mechanism caused by an increased processing of the NC/p1 cleavage site
    Nijhuis, M
    van Maarseveen, N
    Schipper, P
    Glass, B
    Dulude, D
    de Jong, D
    Goedegebuure, I
    Brakier-Gingras, L
    Kraeusslich, HG
    Boucher, C
    [J]. ANTIVIRAL THERAPY, 2005, 10 (04) : S117 - S117
  • [5] Novel HIV gag based protease drug resistance mechanism caused by an increased processing of the NC/p1 cleavage site
    Nijhuis, M
    van Maarseveen, N
    Schipper, P
    Glass, B
    Dulude, D
    de Jong, D
    Goedegebuure, I
    Brakier-Gingras, L
    Kraeusslich, H
    Boucher, C
    [J]. ANTIVIRAL THERAPY, 2005, 10 : S117 - S117
  • [6] CLEAVAGE OF HIV-1 GAG POLYPROTEIN SYNTHESIZED INVITRO - SEQUENTIAL CLEAVAGE BY THE VIRAL PROTEASE
    ERICKSONVIITANEN, S
    MANFREDI, J
    VIITANEN, P
    TRIBE, DE
    TRITCH, R
    HUTCHISON, CA
    LOEB, DD
    SWANSTROM, R
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (06) : 577 - 591
  • [7] Polymorphism of HIV type 1 Gag p7/p1 and p1/p6 cleavage sites: Clinical significance and implications for resistance to protease inhibitors
    Bally, F
    Martinez, R
    Peters, S
    Sudre, P
    Telenti, A
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (13) : 1209 - 1213
  • [8] The regulation of sequential processing of HIV-1 gag by the viral protease
    Pettit, SC
    Sheng, NJ
    Tritch, R
    Erickson-Viitanen, S
    Swanstrom, R
    [J]. ASPARTIC PROTEINASES: RETROVIRAL AND CELLULAR ENZYMES, 1998, 436 : 15 - 25
  • [9] SUBSTITUTIONS AT THE P2' SITE OF GAG P17-P24 AFFECT CLEAVAGE EFFICIENCY BY HIV-1 PROTEASE
    MARGOLIN, N
    HEATH, W
    OSBORNE, E
    LAI, M
    VLAHOS, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 167 (02) : 554 - 560
  • [10] Mutations in HIV-1 gag cleavage sites and their association with protease mutations
    Koch, N
    Yahi, N
    Fantini, J
    Tamalet, C
    [J]. AIDS, 2001, 15 (04) : 526 - 528
12345